Published in Vaccine Weekly, October 20th, 2004
According to a study from France, "Immunization against components of the renin-angiotensin system offers a potential alternative to daily medication in some patients with hypertension or heart failure. Our primary objective was to determine whether a sustained antibody titer to Ang I (angiotensin I) can be achieved in hypertensive patients. The secondary objective was to determine whether the antibodies block the renin system."
"Patients (n=27) with essential hypertension responsive to an ACEi (angiotensin-converting enzyme...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly